SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017210
Filing Date
2019-05-08
Accepted
2019-05-08 16:16:20
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20190331.htm 10-Q 1327406
2 EX-4.2 abio-ex42_106.htm EX-4.2 6917
3 EX-31.1 abio-ex311_8.htm EX-31.1 8580
4 EX-31.2 abio-ex312_7.htm EX-31.2 8538
5 EX-32.1 abio-ex321_6.htm EX-32.1 11188
6 GRAPHIC glkcbrtskerv000001.jpg GRAPHIC 121866
  Complete submission text file 0001564590-19-017210.txt   3716902

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20190331.xml EX-101.INS 489512
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20190331.xsd EX-101.SCH 32376
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20190331_cal.xml EX-101.CAL 25778
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20190331_def.xml EX-101.DEF 93922
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20190331_lab.xml EX-101.LAB 271631
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20190331_pre.xml EX-101.PRE 189837
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 19806804
SIC: 2835 In Vitro & In Vivo Diagnostic Substances